SurpassMD review
Low, conditioned three ways
Semaglutide from $124 a month and tirzepatide from $184, with eligibility, dose and provider approval all named as conditions on those figures.
Our verdict
SurpassMD puts a low number on the page and, in the same breath, the three things that can move it. The wording is its own: semaglutide “starts as low as $124/m ... for eligible patients. Actual pricing depends on medication, dose, and provider approval.” A figure gated on three unquantified variables is a starting point rather than a quote. Saying so plainly is rarer in this market than the low number is, and it counts for something.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- compounded semaglutide
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 51
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
- Availability
- 51 jurisdictions
- Updated
- September 2026
What it is
A telehealth service across 51 jurisdictions prescribing compounded semaglutide and tirzepatide by weekly injection, advertising each as a from-price rather than a fixed monthly rate.
How it works
What a patient pays is settled after an intake, not before it. SurpassMD names four inputs into that figure — eligibility, the medication selected, the dose and a provider's approval — on its homepage and again in its FAQ. How far any of them can lift the bill is not stated.
Pricing transparency
Semaglutide is advertised from $124 a month and tirzepatide from $184, a $60 spread between the two molecules. Both carry identical qualifying language: the figure applies to eligible patients, and actual pricing depends on medication, dose and provider approval. No ceiling is published above either floor.
Branded vs compounded
Compounded semaglutide and tirzepatide by weekly injection. Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, efficacy or quality before dispensing.
Pros and watch-outs
What we like
- Every condition on the price is stated openly
- $124 is a low published entry point
- Only $60 separates the two molecules
- 51 jurisdictions
Watch-outs
- Eligibility, dose and approval can all move it
- No ceiling published above either floor
- The real figure arrives after an intake
- Injection only
Best for
Buyers willing to complete an intake to learn their actual rate.
Who should look elsewhere
Anyone who needs a firm number before starting a consultation.
How SurpassMD compares
A few alternatives worth a look, depending on what you’re optimizing for.
- SkinnyRx
A discounted rate, if it lasts
See SkinnyRx → - Bodybuilding Health+
A headline that is the month-to-month rate
See Bodybuilding Health+ → - Oak
Flat dose pricing without a subscription
See Oak →
More compounded semaglutide sellers reviews: HumeCare+Idgie HealthInstaRXIvy RxJune HealthKERNX Health
Evidence & trials · Reviewed and last verified September 2026
How we assessed this. This review reflects GLP Loss’s own read of SurpassMD’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Will SurpassMD actually charge $124 a month?
- Possibly, and possibly not. The site says semaglutide “starts as low as $124/m ... for eligible patients”, and that actual pricing depends on medication, dose and provider approval. That is a floor with three gates standing in front of it.
- What lifts the price above the advertised figure?
- Three things, all named by SurpassMD: which medication is prescribed, what dose it is, and whether a provider approves the request. How much each one adds is not published, so the spread between the floor and a real bill is unknown.
- How much more is tirzepatide?
- $60 a month at the advertised floors, $184 against $124. The same qualifiers attach to both, so that gap compares two starting points rather than two settled rates.
- Does SurpassMD cover my state?
- It lists 51 jurisdictions, so coverage is unlikely to be the obstacle. The open question here is the price rather than the map, since the advertised figure is a floor and nothing quantifies what sits above it.
- Is SurpassMD legit?
- SurpassMD is a compounded semaglutide sellers service. Its stated availability: 51 jurisdictions. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is SurpassMD expensive compared with other compounded semaglutide sellers providers?
- SurpassMD publishes a starting figure of $124/mo. Across the 115 compounded semaglutide sellers providers we review that publish a single monthly figure, those run $76 to $369 with a median of $170, which puts SurpassMD below the median, toward the cheaper end. The other 5 compounded semaglutide sellers providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.